Cromwell Holdings’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$146K Buy
277
+31
+13% +$17.4K 0.07% 270
2026
Q1
$138K Hold
246
0.08% 257
2025
Q4
$166K Hold
246
0.09% 212
2025
Q3
$157K Hold
246
0.08% 228
2025
Q2
$132K Buy
246
+10
+4% +$4.78K 0.08% 245
2025
Q1
$99.1K Sell
236
-12
-5% -$5.21K 0.06% 292
2024
Q4
$103K Sell
248
-1
-0.4% -$439 0.06% 284
2024
Q3
$126K Buy
249
+17
+7% +$8.26K 0.08% 249
2024
Q2
$113K Buy
+232
New +$116K 0.07% 255

Other funds holding IDXX

Cromwell Holdings's IDXX Position: Q2 2026 in Review

Cromwell Holdings increased its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, buying an estimated $17.4K and bringing the position to 277 shares worth $146K. The position accounts for 0.07% of the portfolio, ranked #270.

Cromwell Holdings first reported a position in IDXX in Q2 2024 and has held it in 9 quarters since. The position peaked at $166K in Q4 2025. 280 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cromwell Holdings held 277 shares of Idexx Laboratories worth $146K as of Q2 2026.
  • Cromwell Holdings bought 31 Idexx Laboratories shares in Q2 2026, an estimated $17.4K.
  • Idexx Laboratories made up 0.07% of Cromwell Holdings's portfolio in Q2 2026, its #270 holding.
  • Cromwell Holdings first reported a position in Idexx Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Cromwell Holdings's Idexx Laboratories position peaked at $166K in Q4 2025.
  • 280 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.